| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $980.6M | +3.3% |
| Cost of Revenue | $545.3M | +3.3% |
| Gross Profit | $435.3M | +3.3% |
| R&D Expense | $95.5M | -0.0% |
| SG&A Expense | $195.7M | +11.2% |
| Operating Income | $94.0M | -15.0% |
| Pre-tax Income | $69.6M | -11.9% |
| Income Tax | $15.8M | +5.6% |
| Net Income | $53.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $380.9M | +234.1% |
| Accounts Receivable | $184.9M | +22.4% |
| Inventory | $188.3M | +30.2% |
| Current Assets | $782.6M | +80.5% |
| Total Assets | $1.81B | +30.1% |
| Current Liabilities | $212.4M | +26.6% |
| Long-term Debt | $212.5M | -48.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.1M | -59.6% |
| Capital Expenditures | $15.6M | -8.9% |
| Investing Cash Flow | -$74.3M | +64.3% |
| Financing Cash Flow | $276.3M | +385.3% |
| Free Cash Flow | $48.4M | -65.7% |
| -16.0% |
| EPS (Basic) | $1.47 | -17.4% |
| EPS (Diluted) | $1.47 | -16.9% |
| Total Liabilities |
| $492.8M |
| -23.3% |
| Stockholders' Equity | $1.31B | +76.2% |